Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -7.60%489.63M | 10.83%910.17M | 16.67%529.93M | -22.57%821.24M | -20.31%454.2M | 6.30%1.06B | 35.08%569.93M | 41.03%997.84M | -7.84%421.91M | -41.64%707.55M |
| Operating income | -7.60%489.63M | 10.83%910.17M | 16.67%529.93M | -22.57%821.24M | -20.31%454.2M | 6.30%1.06B | 35.08%569.93M | 41.03%997.84M | -7.84%421.91M | -41.64%707.55M |
| Cost of sales | -11.34%-375.83M | 11.07%-587.71M | 5.44%-337.55M | 26.41%-660.88M | 26.11%-356.98M | -7.99%-898.01M | -40.32%-483.12M | -46.44%-831.59M | 10.22%-344.29M | 42.63%-567.86M |
| Operating expenses | -11.34%-375.83M | 11.07%-587.71M | 5.44%-337.55M | 26.41%-660.88M | 26.11%-356.98M | -7.99%-898.01M | -40.32%-483.12M | -46.44%-831.59M | 10.22%-344.29M | 42.63%-567.86M |
| Gross profit | -40.84%113.8M | 101.09%322.46M | 97.88%192.38M | -1.42%160.36M | 12.00%97.22M | -2.15%162.68M | 11.84%86.81M | 19.01%166.25M | 4.48%77.62M | -37.21%139.69M |
| Selling expenses | 27.06%-9.73M | -1.23%-16.92M | -41.71%-13.35M | 4.21%-16.72M | 8.08%-9.42M | 7.69%-17.45M | 24.37%-10.25M | 4.46%-18.91M | -34.01%-13.55M | 34.36%-19.79M |
| Administrative expenses | -5.27%-47.9M | -6.75%-92.12M | -16.71%-45.5M | 6.99%-86.29M | -9.90%-38.99M | -12.75%-92.78M | 7.26%-35.48M | -3.52%-82.29M | -21.34%-38.25M | 6.64%-79.49M |
| Impairment and provision | ---- | -50.95%-184.28M | ---- | -193.91%-122.08M | ---- | 62.71%-41.54M | ---- | -5,083.76%-111.4M | ---- | -128.17%-2.15M |
| -Other impairment is provision | ---- | -50.95%-184.28M | ---- | -193.91%-122.08M | ---- | 62.71%-41.54M | ---- | -5,083.76%-111.4M | ---- | -128.17%-2.15M |
| Special items of operating profit | 82.51%-15.58M | -37.07%74.94M | -245.30%-89.09M | 221.95%119.09M | 5.84%-25.8M | -62.41%36.99M | -247.55%-27.4M | 56.23%98.41M | 72.91%18.57M | 316.51%62.99M |
| Operating profit | -8.67%40.59M | 91.47%104.09M | 93.10%44.45M | 13.49%54.36M | 68.14%23.02M | -8.00%47.9M | -69.16%13.69M | -48.58%52.07M | 2.29%44.39M | -22.07%101.26M |
| Financing cost | 55.51%-827K | 8.01%-2.31M | 11.94%-1.86M | 24.74%-2.51M | -8.65%-2.11M | -33.83%-3.34M | -38.88%-1.94M | -19.58%-2.49M | 1.13%-1.4M | 61.98%-2.08M |
| Special items of earning before tax | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --3.54M |
| Earning before tax | -6.63%39.77M | 96.29%101.78M | 103.70%42.59M | 16.35%51.85M | 77.98%20.91M | -10.10%44.57M | -72.68%11.75M | -51.74%49.57M | 2.40%42.99M | -17.47%102.72M |
| Tax | 61.64%-6.38M | -272.07%-28.13M | -382.26%-16.64M | -913.67%-7.56M | -215.19%-3.45M | 114.49%929K | 171.04%3M | -39.47%-6.41M | 5.70%-4.22M | 60.76%-4.6M |
| After-tax profit from continuing operations | 28.64%33.38M | 66.29%73.65M | 48.65%25.95M | -2.64%44.29M | 18.42%17.46M | 5.41%45.49M | -61.98%14.74M | -56.01%43.16M | 3.37%38.77M | -12.97%98.12M |
| Earning after tax | 28.64%33.38M | 66.29%73.65M | 48.65%25.95M | -2.64%44.29M | 18.42%17.46M | 5.41%45.49M | -61.98%14.74M | -56.01%43.16M | 3.37%38.77M | -12.97%98.12M |
| Minority profit | -19.23%1.18M | 1,701.91%12.27M | 1,007.45%1.46M | -89.13%681K | 87.84%-161K | 1.62%6.27M | -436.90%-1.32M | -23.88%6.17M | -61.73%393K | 243.91%8.1M |
| Profit attributable to shareholders | 31.50%32.2M | 40.75%61.38M | 39.00%24.49M | 11.17%43.61M | 9.66%17.62M | 6.04%39.23M | -58.14%16.07M | -58.90%37M | 5.20%38.38M | -18.45%90.02M |
| Dividend per share | 0.00%0.04 | ---- | 100.00%0.04 | ---- | --0.02 | ---- | ---- | ---- | 11.11%0.02 | ---- |
| Basic earnings per share | 32.10%0.0214 | 41.96%0.0406 | 40.87%0.0162 | 11.28%0.0286 | 9.52%0.0115 | 7.08%0.0257 | -57.83%0.0105 | -59.25%0.024 | 4.18%0.0249 | -18.42%0.0589 |
| Diluted earnings per share | 32.10%0.0214 | 41.96%0.0406 | 40.87%0.0162 | 11.28%0.0286 | 9.52%0.0115 | 7.08%0.0257 | -57.83%0.0105 | -59.25%0.024 | 4.18%0.0249 | -18.42%0.0589 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.